Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Charles Ford

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Alimentary Pharmacology & Therapeutics|August 28, 2020
Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvementGianluca Ianiro, Serena Porcari, Alexander Charles Ford, et al.
Frontline Gastroenterology|January 25, 2021
Acceptability of a 'treat to target' approach in inflammatory bowel disease to patients in clinical remissionChristian Selinger, Jenelyn Carbonell, John Kane, et al.
Gut|August 1, 2020
Global prevalence of Barrett's oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysisLeonardo Henry Eusebi, Giovanna Grazia Cirota, Rocco Maurizio Zagari, et al.
Gut|July 16, 2024
Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysisSerena Porcari, Maria Rosa Ingrosso, Marcello Maida, et al.
Journal of Autoimmunity|April 25, 2023
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysisSerena Porcari, Simon Mark Dahl Baunwall, Annamaria Sara Occhionero, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|September 22, 2018
Clinical application of dietary therapies in irritable bowel syndromeAnupam Rej, Amanda Avery, Alexander Charles Ford, et al.
Health Technology Assessment (Winchester, England)|March 13, 2025
Management of diarrhoea in patients with stable ulcerative colitis with low FODMAP diet, amitriptyline, ondansetron or loperamide: the MODULATE RCTLauren A Moreau, Alexander Charles Ford, Matthew James Brookes, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Alimentary Pharmacology & Therapeutics|August 28, 2020
Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvementGianluca Ianiro, Serena Porcari, Alexander Charles Ford, et al.
Frontline Gastroenterology|January 25, 2021
Acceptability of a 'treat to target' approach in inflammatory bowel disease to patients in clinical remissionChristian Selinger, Jenelyn Carbonell, John Kane, et al.
Gut|August 1, 2020
Global prevalence of Barrett's oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysisLeonardo Henry Eusebi, Giovanna Grazia Cirota, Rocco Maurizio Zagari, et al.
Gut|July 16, 2024
Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysisSerena Porcari, Maria Rosa Ingrosso, Marcello Maida, et al.
Journal of Autoimmunity|April 25, 2023
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysisSerena Porcari, Simon Mark Dahl Baunwall, Annamaria Sara Occhionero, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|September 22, 2018
Clinical application of dietary therapies in irritable bowel syndromeAnupam Rej, Amanda Avery, Alexander Charles Ford, et al.
Health Technology Assessment (Winchester, England)|March 13, 2025
Management of diarrhoea in patients with stable ulcerative colitis with low FODMAP diet, amitriptyline, ondansetron or loperamide: the MODULATE RCTLauren A Moreau, Alexander Charles Ford, Matthew James Brookes, et al.
Pageof 2